News provided by. NeuroSense. 24 Nov, 2025, 16:56 IST. Share this article … (FDA) has completed the review of the Investigational New Drug (IND) …
NeuroSense Receives FDA Clearance to Initiate Pivotal Phase 3 Trial for PrimeC in ALS
Share This Story, Choose Your Platform!
About the Author: AJDesign77
